BREAKING: Helion, a nuclear fusion startup, secured a $465M Series G led by Thrive Capital.
The startup aims to be the first to deliver commercial nuclear fusion power.
a standing ovation for daraxonrasib at asco. over 40k oncologists, entrepreneurs, investors, and patient advocates together celebrating revmed's breakthru in the fight against pancreatic cancer. u never forget these moments. it's what innovation is all about.